Clinical study on the bioequivalence of two tablet formulations of flurbiprofen

Summary Flurbiprofen (CAS 5104-49-4) is a member of phenylaikanoic acid derivative group of nonsteroid anti-inflammatory drugs. It exhibits anti-inflammatory, analgesic and antipyretic activities. Two different tablets containing flurbiprofen (FLU) were investipted in 24 healthy volunteers to prove...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of drug metabolism and pharmacokinetics Vol. 34; no. 1; pp. 1 - 5
Main Authors:	Ozbay, Latif, Unal, Durisehvar Ozer, Cakici, Iclal, Fenercioglu, Ayşen, Erol, Dilek
Format:	Journal Article
Language:	English
Published:	Paris Springer-Verlag 01-01-2009 Médecine & hygiène
Subjects:	Adolescent Adult Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Area Under Curve Biological and medical sciences Biomedical and Life Sciences Biomedicine Chemistry, Pharmaceutical Chromatography, High Pressure Liquid Cross-Over Studies Double-Blind Method Flurbiprofen - administration & dosage Flurbiprofen - pharmacokinetics Flurbiprofen - therapeutic use Human Physiology Humans Male Medical Biochemistry Medical sciences Middle Aged Pharmaceutical Sciences/Technology Pharmacology. Drug treatments Pharmacology/Toxicology Pharmacy Reproducibility of Results Spectrophotometry, Ultraviolet Tablets Therapeutic Equivalency Young Adult Bioequivalence flurbiprofen pharmacokinetics Non steroidal antiinflammatory agent Prostaglandin-endoperoxide synthase Enzyme Formulation Dosage form Enzyme inhibitor Arylpropionic acid derivatives Tablet Oxidoreductases Pharmacokinetics Flurbiprofen
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!